Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06490328
PHASE3

Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer

Sponsor: Dongkook Pharmaceutical Co., Ltd.

View on ClinicalTrials.gov

Summary

A phase 3, multi-center, single-group, open-label study to evaluate the efficacy and safety of DKF-MA102 in patients with prostate cancer.

Official title: A Phase 3, Multi-center, Single-group, Open-label Study to Evaluate the Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer

Key Details

Gender

MALE

Age Range

19 Years - Any

Study Type

INTERVENTIONAL

Enrollment

154

Start Date

2024-05-30

Completion Date

2025-05-20

Last Updated

2024-07-08

Healthy Volunteers

No

Interventions

DRUG

DKF-MA102

Administered twice at 12-week intervals

Locations (1)

Ewha Womans University mokdong Hospital

Seoul, South Korea